OACP IE LTD

OaCP, with the slogan "FAST LABORATORY DIAGNOSTICS," is a company focused on developing chemical and biotechnological products for rapid diagnostics in the fields of oncology and cytogenetics. The company emphasizes the importance of quality work in molecular biology and molecular cytogenetics, aiming to make it cost-effective through their product line, Smart-ISH Solve, and rapid with Rapid-ISH Integra. Their ongoing research collaboration with the University of Bologna led to the development of the DoMo Genetics reagent line, and they continue to strive for innovation.

Founded in 2017 and headquartered in Ireland, OaCP operates in the Health Care industry. Their most recent investment was a Convertible Note investment on 07 April 2020, with participation from SOSV and RebelBio. The company's mission is to provide faster, budget-conscious, and user-friendly tools for professionals in the molecular biology laboratory to enhance the quality of life for oncology patients, entrepreneurs, and researchers.